Search Results

There are 14736 results for: content related to: Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer

  1. You have free access to this content
    Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer

    BJU International

    Volume 115, Issue 5, May 2015, Pages: 744–752, Stéphane Oudard, Gero Kramer, Orazio Caffo, Lorraine Creppy, Yohan Loriot, Steinbjoern Hansen, Mats Holmberg, Frederic Rolland, Jean-Pascal Machiels and Michael Krainer

    Version of Record online : 29 DEC 2014, DOI: 10.1111/bju.12845

  2. You have free access to this content
    CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: E760–E772, Michel D. Wissing, Jules L.L.M. Coenen, Pieter van den Berg, Hans M. Westgeest, Alfons J.M. van den Eertwegh, Inge M. van Oort, Monique M. Bos, André M. Bergman, Paul Hamberg, Albert J. ten Tije, Maartje Los, Martijn P.J.K. Lolkema, Ronald de Wit and Hans Gelderblom

    Version of Record online : 3 OCT 2014, DOI: 10.1002/ijc.29231

  3. You have free access to this content
    Sorafenib rechallenge in patients with metastatic renal cell carcinoma

    BJU International

    Volume 110, Issue 6b, September 2012, Pages: E228–E234, Masahiro Nozawa, Yutaka Yamamoto, Takafumi Minami, Nobutaka Shimizu, Yuji Hatanaka, Hidenori Tsuji and Hirotsugu Uemura

    Version of Record online : 14 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10905.x

  4. You have free access to this content
    Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 1, March 2012, Pages: 31–42, Phillip PARENTE, Francis PARNIS and Howard GURNEY

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1743-7563.2011.01506.x

  5. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  6. You have free access to this content
    Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 974–978, Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill and Philippe Beuzeboc

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09296.x

  7. You have free access to this content
    Second-line therapy for castrate-resistant prostate cancer: A literature review

    Asia-Pacific Journal of Clinical Oncology

    Volume 7, Issue 3, September 2011, Pages: 212–223, S C-H KAO, E HOVEY and G MARX

    Version of Record online : 28 AUG 2011, DOI: 10.1111/j.1743-7563.2011.01421.x

  8. Docetaxel Nanotechnology in Anticancer Therapy

    ChemMedChem

    Volume 7, Issue 6, June 2012, Pages: 952–972, Pengxiang Zhao and Didier Astruc

    Version of Record online : 19 APR 2012, DOI: 10.1002/cmdc.201200052

  9. You have free access to this content
    Sunitinib rechallenge in metastatic renal cell carcinoma patients

    Cancer

    Volume 116, Issue 23, 1 December 2010, Pages: 5400–5406, Ivan N. Zama, Thomas E. Hutson, Paul Elson, James M. Cleary, Toni K. Choueiri, Daniel Y.C. Heng, Nikhil Ramaiya, M. Dror Michaelson, Jorge A. Garcia, Jennifer J. Knox, Bernard Escudier and Brian I. Rini

    Version of Record online : 2 NOV 2010, DOI: 10.1002/cncr.25583

  10. You have full text access to this OnlineOpen article
    Successful erlotinib rechallenge after both gefitinib- and erlotinib-induced interstitial lung diseases

    Respirology Case Reports

    Volume 1, Issue 1, September 2013, Pages: 17–19, Nobuhito Arakawa, Akihiro Tsujita, Noriko Saito, Shigemi Ishikawa and Shoji Ohno

    Version of Record online : 1 SEP 2013, DOI: 10.1002/rcr2.12

  11. Docetaxel-induced photo-recall phenomenon

    Photodermatology, Photoimmunology & Photomedicine

    Volume 28, Issue 4, August 2012, Pages: 222–223, Catherine Droitcourt, Hélêne Le Hô, Henri Adamski, François Le Gall and Alain Dupuy

    Version of Record online : 1 JUL 2012, DOI: 10.1111/j.1600-0781.2012.00669.x

  12. You have free access to this content
    Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1135–1148, Heidi Barth, Jolanta Rybczynska, Romuald Patient, Youkyung Choi, Ronda K. Sapp, Thomas F. Baumert, Kris Krawczynski and T. Jake Liang

    Version of Record online : 11 AUG 2011, DOI: 10.1002/hep.24489

  13. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x

  14. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity

    The Prostate

    Volume 72, Issue 6, 1 May 2012, Pages: 661–667, Peter Makhov, Konstantin Golovine, Daniel Canter, Alexander Kutikov, Jay Simhan, Melany M. Corlew, Robert G. Uzzo and Vladimir M. Kolenko

    Version of Record online : 27 JUL 2011, DOI: 10.1002/pros.21469

  15. You have free access to this content
    Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment

    Hepatology

    Volume 62, Issue 2, August 2015, Pages: 546–557, Mala Chakraborty, Aaron M. Fullerton, Kenrick Semple, Lynette S. Chea, William R. Proctor, Mohammed Bourdi, David E. Kleiner, Xiangbin Zeng, Pauline M. Ryan, Pradeep K. Dagur, Julia D. Berkson, Timothy P. Reilly and Lance R. Pohl

    Version of Record online : 25 MAR 2015, DOI: 10.1002/hep.27764

  16. Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity

    International Journal of Gynecological Cancer

    Volume 15, Issue 5, September 2005, Pages: 780–784, M.J. KANDEL, A. LOEHR, P. HARTER, A. TRAUT, K. GNAUERT and A. Du BOIS

    Version of Record online : 12 SEP 2005, DOI: 10.1111/j.1525-1438.2005.00136.x

  17. Docetaxel-Associated Epiphora

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 6, June 2006, Pages: 853–867, Dr. Polly E. Kintzel, Dr. Laura B. Michaud and Dr. Marianne K. Lange

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.6.853

  18. You have free access to this content
    Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: A systematic review

    Hepatology

    Volume 52, Issue 6, December 2010, Pages: 2216–2222, Christine M. Hunt

    Version of Record online : 23 NOV 2010, DOI: 10.1002/hep.24022

  19. You have free access to this content
    Conclusiveness of rechallenge in the interpretation of adverse drug reactions.

    British Journal of Clinical Pharmacology

    Volume 23, Issue 1, January 1987, Pages: 73–79, M Girard

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1987.tb03011.x

  20. You have free access to this content
    Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study

    BJU International

    Volume 115, Issue 1, January 2015, Pages: 65–73, Florence Joly, Remy Delva, Loïc Mourey, Emmanuel Sevin, Emmanuelle Bompas, Lionel Vedrine, Alain Ravaud, Jean-Christophe Eymard, Nicole Tubiana-Mathieu, Claude Linassier, Nadine Houede, Aline Guillot, François Ringensen, Oana Cojocarasu, Bruno Valenza, Alexandra Leconte, Stéphanie Lheureux, Bénédicte Clarisse and Stéphane Oudard

    Version of Record online : 15 DEC 2014, DOI: 10.1111/bju.12552